Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats

References

• ZhouZLYangYXDingJLiYCMiaoZHTriptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanismsNat Prod Rep201229445747522270059
   PubMed Web of Science ®Google Scholar
• XueXGongLQiXKnockout of hepatic P450 reductase aggravates triptolide-induced toxicityToxicol Lett20112051475421596114
   PubMed Web of Science ®Google Scholar
• LiJJinJLiMRole of Nrf2 in protection against triptolide-induced toxicity in rat kidney cellsToxicol Lett2012213219420222820427
   PubMed Web of Science ®Google Scholar
• YeXLiWYanYEffects of cytochrome P4503A inducer dexamethasone on the metabolism and toxicity of triptolide in ratToxicol Lett2010192221222019879934
   PubMed Web of Science ®Google Scholar
• ChenHChangXWengTA study of microemulsion systems for transdermal delivery of triptolideJ Control Release2004983427436
   PubMed Web of Science ®Google Scholar
• XueJJiaXBTanXBJiaDSJiangJZhangLYDetermination of apparent oil/water partition coefficient and absorption prediction of triptolideChin Pharm J2009442015601563
   Google Scholar
• ChessariGWoodheadAJFrom fragment to clinical candidate – a historical perspectiveDrug Discov Today20091413–1466867519427404
   PubMed Web of Science ®Google Scholar
• MaoYTaoXLipskyPEPharmacokinetics of triptolide. Development and application of a high performance liquid chromatographic method for quantitation of triptolide in plasmaJ Liq Chromatogr Relat Technol199922913551366
   Web of Science ®Google Scholar
• ShaoFWangGXieHZhuXSunJAJPharmacokinetic study of triptolide, a constituent of immunosuppressive chinese herb medicine, in ratsBiol Pharm Bull200730470270717409506
   PubMed Web of Science ®Google Scholar
• LiWLiuYHeYQCharacterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomesXenobiotica200838121551156518982531
   PubMed Web of Science ®Google Scholar
• LiuLJiangZLiuJSex differences in subacute toxicity and hepatic microsomal metabolism of triptolide in ratsToxicology20102711–2576320223271
   PubMed Web of Science ®Google Scholar
• MüllerRHRadtkeMWissingSANanostructured lipid matrices for improved microencapsulation of drugsInt J Pharm20022421–212112812176234
   PubMed Web of Science ®Google Scholar
• SouzaLGSilvaEJMartinsALDevelopment of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged releaseEur J Pharm Biopharm201179118919621352915
   PubMed Web of Science ®Google Scholar
• ZhuangCYLiNWangMPreparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailabilityInt J Pharm20103941–217918520471464
   PubMed Web of Science ®Google Scholar
• MüllerRHPetersenRDHommossAPardeikeJNanostructured lipid carriers (NLC) in cosmetic dermal productsAdv Drug Deliv Rev2007596522530
   PubMed Web of Science ®Google Scholar
• PardeikeJHommossAMüllerRHLipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal productsInt J Pharm20093661–217018418992314
   PubMed Web of Science ®Google Scholar
• GargMDuttaTJainNKReduced hepatic toxicity, enhanced cellular uptake and altered pharmacokinetics of stavudine loaded galactosylated liposomesEur J Pharm Biopharm2007671768517303396
   PubMed Web of Science ®Google Scholar
• FanYFXieYLiuLPaeoniflorin reduced acute toxicity of aconitine in rats is associated with the pharmacokinetic alteration of aconitineJ Ethnopharmacol2012141270170821930193
   PubMed Web of Science ®Google Scholar
• MeiZLiXWuQHuSYangXThe research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticlePharmacol Res200551434535115683748
   PubMed Web of Science ®Google Scholar
• ZhangCGuCPengFPreparation and optimization of triptolide-loaded solid lipid nanoparticles for oral delivery with reduced gastric irritationMolecules20131811133401335624172242
   PubMed Web of Science ®Google Scholar
• JoshiMPatravaleVNanostructured lipid carrier (NLC) based gel of celecoxibInt J Pharm20083461–212413217651933
   PubMed Web of Science ®Google Scholar
• ChenCCTsaiTHHuangZRFangJYEffects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokineticsEur J Pharm Biopharm201074347448220060469
   PubMed Web of Science ®Google Scholar
• JoshiMPathakSSharmaSPatravaleVDesign and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: NanojectInt J Pharm20083641119126
   PubMed Web of Science ®Google Scholar
• XuLChenHXuHYangXAnti-tumour and immuno-modulation effects of triptolide-loaded polymeric micellesEur J Pharm Biopharm200870374174818761405
   PubMed Web of Science ®Google Scholar
• XueMZhaoYLiXJComparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in ratsEur J Pharm Sci201247471371722677813
   PubMed Web of Science ®Google Scholar
• KasongoKWPardeikeJMüllerRHWalkerRBSelection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriersJ Pharm Sci2011100125185519622020815
   PubMed Web of Science ®Google Scholar
• zur MühlenASchwarzCMehnertWSolid lipid nanoparticles (SLN) for controlled drug delivery – drug release and release mechanismEur J Pharm Biopharm19984521491559704911
   PubMed Web of Science ®Google Scholar
• BalakrishnanPLeeBJOhDHEnhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS)Eur J Pharm Biopharm200972353954519298857
   PubMed Web of Science ®Google Scholar
• KovacevicASavicSVuletaGMüllerRHKeckCMPolyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structureInt J Pharm20114061–216317221219990
   PubMedGoogle Scholar
• JenningVThünemannAFGohlaSHCharacterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipidsInt J Pharm2000199216717710802410
   PubMed Web of Science ®Google Scholar
• PugliaCBoninaFRizzaLLipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studiesJ Pharm Sci2012101130131121905033
   PubMed Web of Science ®Google Scholar
• WangJJLiuKSSungKCTsaiCYFangJYLipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injectionEur J Pharm Sci200938213814619591929
   PubMed Web of Science ®Google Scholar
• FuQHuangXShuBInhibition of mitochondrial respiratory chain is involved in triptolide-induced liver injuryFitoterapia20118281241124821907767
   PubMed Web of Science ®Google Scholar
• NiBJiangZHuangXMale reproductive toxicity and toxicokinetics of triptolide in ratsArzneimittelforschung2008581267368019202740
   PubMed Web of Science ®Google Scholar
• AwadMEAbdel-RahmanMSHassanSAAcrylamide toxicity in isolated rat hepatocytesToxicol In Vitro199812669970420654459
   PubMed Web of Science ®Google Scholar
• CourrègesJPBachaJAboudEAndréLLamarcaR[Renal artery stenosis and chronic renal failure in NIDDM]Arch Mal Coeur Vaiss199891810771082 French9749169
   PubMedGoogle Scholar
• LiuMDongJYangYYangXXuHEffect of poly(D, L-lactic acid) nanoparticles as triptolide carrier on abating rats renal toxicity by NMR-based metabolic analysisJ Nanosci Nanotechnol2008873493349919051901
   PubMed Web of Science ®Google Scholar
• AkbayACinarKUzunalimoğluOSerum cytotoxin and oxidant stress markers in N-acetylcysteine treated thioacetamide hepatotoxicity of ratsHum Exp Toxicol19991811669676
   PubMed Web of Science ®Google Scholar
• KonarVKaraHYilmazMDayangacAKaratasFEffects of selenium and vitamin E, in addition to melatonin, against oxidative stress caused by cadmium in ratsBiol Trace Elem Res2007118213113717873355
   PubMed Web of Science ®Google Scholar
• WassvikCMHolménAGDraheimRArturssonPBergströmCAMolecular characteristics for solid-state limited solubilityJ Med Chem200851103035303918396854
   PubMed Web of Science ®Google Scholar
• BergströmCAWassvikCMJohanssonKHubatschIPoorly soluble marketed drugs display solvation limited solubilityJ Med Chem200750235858586217929794
   PubMed Web of Science ®Google Scholar
• ChenXQGudmundssonOSHagemanMJApplication of lipid-based formulations in drug discoveryJ Med Chem201255187945795622779739
   PubMed Web of Science ®Google Scholar
• ChenYCLiuDZLiuJJChangTWHoHOSheuMTDevelopment of terbinafine solid lipid nanoparticles as a topical delivery systemInt J Nanomedicine201274409441822923986
   PubMed Web of Science ®Google Scholar
• LuoYChenDRenLZhaoXQinJSolid lipid nanoparticles for enhancing vinpocetine’s oral bioavailabilityJ Control Release20061141535916828192
   PubMed Web of Science ®Google Scholar
• ElnaggarYSEl-MassikMAAbdallahOYSelf-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimizationInt J Pharm20093801–213314119635537
   PubMed Web of Science ®Google Scholar
• Aji AlexMRChackoAJJoseSSoutoEBLopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targetingEur J Pharm Sci2011421–2111820971188
   PubMed Web of Science ®Google Scholar
• YangFRenLZhuoLAnandaSLiuLInvolvement of oxidative stress in the mechanism of triptolide-induced acute nephrotoxicity in ratsExp Toxicol Pathol2012647–890591121530203
   PubMedGoogle Scholar
• XuLQiuYXuHAoWLamWYangXAcute and subacute toxicity studies on triptolide and triptolide-loaded polymeric micelles following intravenous administration in rodentsFood Chem Toxicol20135737137923583804
   PubMed Web of Science ®Google Scholar
• TiyaboonchaiWLimpeanchobNFormulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticlesInt J Pharm20073291–214214917000065
   PubMed Web of Science ®Google Scholar
• JainSValviPUSwarnakarNKThankiKGelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin BMol Pharm2012992542255322845020
   PubMed Web of Science ®Google Scholar